GSK Snaps Up US Biotech Rapt Therapeutics for $2.2bn
GSK just made its first big move under new boss Luke Miels—and it’s a chunky one….
-
-
Investec Targets Mid-Market Businesses in Major Growth Push
Banking giant spots opportunity in “underserved” mid-cap companies Ever noticed how mid-sized businesses often get stuck…
-
Rightmove Shares Tank £1bn as AI Investment Spooks Markets
Rightmove just wiped £1bn off its market value in a single morning. The culprit? A hefty…
-
UK Finance Chiefs Lose Faith as Labour’s Growth Push Stalls
Rising costs. Squeezed margins. Frozen expansion plans. You know things are rough when finance chiefs stop…
